Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial.

Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial. Lancet Neurol. 2015 Aug; 14(8):795-803.

View in: PubMed

collapse authors with profiles